Tag Archive | "Galderma"

Valeant sells its dermatology products for $1.4 billion

Tags: , , ,


Valeant Pharmaceuticals International has entered into an agreement with Nestle to sell all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 billion in cash. Read the full story

Galderma

Tags: , ,


Galderma is a top pharmaceutical company based in Lausanne, Switzerland. Read the full story

Bioventus signs a pharma deal with Galderma for Durolane

Tags: , , ,


Bioventus has entered into pharma deal with Galderma to acquire the international assets for DUROLANE. Read the full story

Galderma: Partnering activity 2009-2014

Tags: ,


Galderma is one of the top global pharmaceutical companies with a dermatology focus area. Read the full story

Galderma – Derma Specialist prioritizing science driven licensing agreements

Tags: , ,


Galderma is one of the world’s largest dermatology and top 50 pharma companies. Read the full story

Galderma: Company profile

Tags: ,


Galderma, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Valeant Pharma & Galderma in a revised pharma alliances arrangement

Tags: , , , ,


Valeant Pharmaceuticals International has reached agreement on terms of a revised pharma alliances aesthetics arrangement with North American Galderma. Read the full story

Partnering Agreements with Galderma

Tags: , ,


This report provides all the information you require to better understand Galderma and its partnering interests and activities over the past seven years Read the full story